Literature DB >> 25523478

Intensified home haemodialysis for managing severe cardiac failure.

Nabil Z Melhem1, Pallavi Yadav, Lynsey Stronach, Daljit K Hothi.   

Abstract

BACKGROUND: Conventional thrice weekly haemodialysis (HD) provides adequate dialysis to prevent mortality, but morbidity is prevalent in both the paediatric and adult population. There has been growing interest in the potential of intensive dialysis regimes entering the realm of optimal dialysis, with superior health and quality of life outcomes. CASE DIAGNOSIS/TREATMENT: We present the case of a 13-year-old girl who had bilateral nephrectomies as a result of bilateral Wilms tumors. In the third year of treatment with conventional HD, she presented with symptomatic progressive cardiac failure, presumably secondary to anthracycline-induced cardiomyopathy. Consequently, she was taken off the renal transplant list and became increasingly dependent on frequent in-centre dialysis sessions to manage her symptoms. Five months after switching to a frequent and extended home HD regime, we observed a tremendous improvement in her health and well-being, with complete reversal of her cardiac dysfunction.
CONCLUSIONS: Home HD is a practically viable option in children with severe cardiac dysfunction. Gentler, more intensive dialysis will draw out and improve the ureamic component of heart disease. This may translate into improved cardiac function.

Entities:  

Mesh:

Year:  2014        PMID: 25523478     DOI: 10.1007/s00467-014-3032-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.

Authors:  Christopher T Chan; John S Floras; Judith A Miller; Robert M A Richardson; Andreas Pierratos
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

2.  Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.

Authors:  Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

3.  Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis.

Authors:  I Mucsi; G Hercz; R Uldall; M Ouwendyk; R Francoeur; A Pierratos
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

Review 4.  Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

Authors:  Diana Iarussi; Paolo Indolfi; Fiorina Casale; Vincenzo Martino; Maria Teresa Di Tullio; Raffaele Calabrò
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Cardiovascular disease in chronic renal failure: pathophysiologic aspects.

Authors:  Gérard M London
Journal:  Semin Dial       Date:  2003 Mar-Apr       Impact factor: 3.455

6.  Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.

Authors:  O Hequet; Q H Le; I Moullet; E Pauli; G Salles; D Espinouse; C Dumontet; C Thieblemont; P Arnaud; D Antal; F Bouafia; B Coiffier
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

7.  Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.

Authors:  Daniela Cardinale; Maria T Sandri; Alessandro Colombo; Nicola Colombo; Marina Boeri; Giuseppina Lamantia; Maurizio Civelli; Fedro Peccatori; Giovanni Martinelli; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690

Review 8.  Anthracyclines in the treatment of cancer. An overview.

Authors:  G N Hortobágyi
Journal:  Drugs       Date:  1997       Impact factor: 9.546

9.  Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

Authors:  R N Foley; P S Parfrey; J D Harnett; G M Kent; C J Martin; D C Murray; P E Barre
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

Review 10.  Treatment-related cardiotoxicity in survivors of childhood cancer.

Authors:  Steven E Lipshultz; Thomas R Cochran; Vivian I Franco; Tracie L Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-10-29       Impact factor: 66.675

View more
  1 in total

1.  Monitoring dialysis adequacy: history and current practice.

Authors:  Linda Ding; James Johnston; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2021-01-05       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.